curocell

CARGO Therapeutics

This biotechnology company develops engineered cell therapies to treat cancer patients with relapsed or resistant lymphoma.

Lyell Immunopharma

This biopharmaceutical company develops chimeric antigen receptor T-cell therapies to treat patients with hematologic malignancies and solid tumours.

T-CURX

This biotech company develops non-viral CAR-T cell therapies to treat patients with leukaemia, lymphoma and solid tumours.

March Biosciences

This clinical-stage company develops CAR-T cell therapies for patients with challenging hematological cancers, including T-cell lymphoma.

Verismo Therapeutics

This company develops chimeric antigen receptor therapies for patients with solid tumours and B-cell lymphomas.

Arcellx

This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.

Orca Bio

This company develops high-precision allogeneic cell therapies to treat patients with blood cancers and autoimmune diseases by replacing diseased immune systems with donor cells.

Caribou Biosciences

This biopharmaceutical company develops genome-edited allogeneic cell therapies to treat patients with hematologic malignancies and other human diseases.